PNAs as novel cancer therapeutics

Author： Luca Mologni  

Publisher： Springer Publishing Company

ISSN： 0929-5666

Source： Letters in Peptide Science, Vol.10, Iss.3-4, 2003-01, pp. : 297-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulation of nucleic acid information processing by PNAs: potential use in anti-viral therapeutics

By Lionel Bastide  

Letters in Peptide Science, Vol. 10, Iss. 3-4, 2003-01 ,pp. : 149-159

Springer Publishing Company

Access to resources Recommend Favorite

Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer

By Liu Ruiwu   Wettersten Hiromi I   Park See-Hyoung   Weiss Robert H  

Future Medicinal Chemistry, Vol. 5, Iss. 9, 2013-06 ,pp. : 991-994

Future Science

Access to resources Recommend Favorite

Individualised cancer therapeutics: dream or reality? Therapeutics construction

By Shen Yuqiao   Senzer Neil   Nemunaitis John  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 11, 2005-11 ,pp. : 1427-1441

Informa Healthcare

Access to resources Recommend Favorite

Immune-based therapeutics for pediatric cancer

By Capitini Christian M   Mackall Crystal L   Wayne Alan S  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 2, 2010-02 ,pp. : 163-178

Informa Healthcare

Access to resources Recommend Favorite

Cancer stem cells: the development of new cancer therapeutics

By Scatena Roberto   Bottoni Patrizia   Pontoglio Alessandro   Giardina Bruno  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 875-892

Informa Healthcare

Access to resources Recommend Favorite